Lymph Node Disease

3

Review clinical trials related to Lymph Node Disease. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

EUS Examination Using EndoSound Vision System vs. Standard Echoendoscope

This is a randomized trial to compare the standard echoendoscope with the newly developed EndoSound Visual System in the evaluation of lesions in the gastrointestinal tract.

Participants needed: 140
Trial details
Age: 18-100Biological sex: AllType: InterventionalSponsor: Orlando Health, Inc.Updated: Apr 1, 2024Locations: 1
Eligibility criteria

Age ≥ 18 years [+1]

Age < 18 years. [+2]

Status: Not yet recruiting

D2 Versus D3 Dissection in Laparoscopic Right Hemicolectomy

Evaluating the differences between D2 and D3 lymphadenectomy in laparoscopic right hemicolectomy in patients with right cancer colon post-operative outcome, intra-operative blood transfusion, post-operative ICU admission, anastomotic leakage, lymph node harvesting in the final specimen, and six months follow up and overall survival time after 5-years

Participants needed: 80
Trial details
Biological sex: AllType: InterventionalSponsor: General Committee of Teaching Hospitals and Institutes, EgyptUpdated: Sep 22, 2023Locations: 1
Eligibility criteria

Patients with right-side colon cancer (caecum, ascending, or hepatic flexure) [+3]

Emergency surgery (obstruction, perforation with generalized peritonitis), [+4]

Status: Recruiting

The Role of Micrometastasis and Isolated Tumor Cells (ITCs) in Endometrial and Cervical Cancer. A Multicenter Study.

The role of small-volume lymph node disease (ITC and micro metastases) among patients with endometrial or cervical cancer submitted to sentinel node (SLN) procedure is not clearly defined. This study was designed to create a dataset of patients with lymph nodal disease. Data on type and volume of lymph nodal disease, therapeutic choices and oncological outcomes (DFS, OS, recurrence rate) will be collected and analyzed. This will allow to define the groups of patients who may need or for whom it can be avoided any adjuvant treatment on the basis of lymph node status.

Participants needed: 500
Trial details
Age: 18+Biological sex: FemaleType: ObservationalSponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoUpdated: Aug 17, 2022Locations: 1
Eligibility criteria

Early stage endometrial cancer scheduled for SLN procedure [+3]

Previous (<5 years) or concomitant malignancy other than non-melanoma skin cance... [+2]